Cellular Defects in CVID Patients with Chronic Lung Disease in the USIDNET Registry

Immunodeficiency

Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry

J Clin Immunol.

Yakaboski E, Fuleihan RL, Sullivan KE, Cunningham-Rundles C, Feuille E

doi: 10.1007/s10875-020-00769-8.

Immunodeficiency

Interstitial lung disease in patients with Common Variable Immunodeficiency Disorders: several different pathologies?

Clin Exp Immunol.

Patel S, Anzilotti C, Lucas M, Moore N, Chapel H

doi: 10.1111/cei.13343.

Immunodeficiency

Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry

J Clin Immunol.

Patrawala M, Cui Y, Peng L, Fuleihan RL, Garabedian EK, Patel K, Guglani L

doi: 10.1007/s10875-019-00738-w.

AcneAtopic DermatitisPsoriasis

Mapping risk factors for Cumulative Life Course Impairment (CLCI) in patients with chronic skin diseases - a systematic review

J Eur Acad Dermatol Venereol

von Stülpnagel CC, Augustin M, Düpmann L, da Silva N, Sommer R

doi: 10.1111/jdv.17348

Alopecia Areata

Histological and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease

J Am Acad Dermatol.

Marks DH, Naftulin JS, Penzi LR, Manatis-Lornell A, Yasuda MR, Chapman CM, Rao SR, Saavedra A, Senna MM

doi: 10.1016/j.jaad.2019.03.031.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Ann Rheum Dis.

Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R, Gonzalez-Gay MA, Martinez-Lopez D, Castrejón I, Alvaro-Gracia JM, Fernández Fernández D, Mera-Varela A, Manrique-Arija S, Mena Vázquez N, Fernandez-Nebro A, RIER Investigators Group., RIER investigators group

doi: 10.1136/annrheumdis-2020-218296.

Psoriatic Arthritis

In Psoriatic Arthritis fatigue is driven by inflammation, disease duration, and chronic pain: An observational DANBIO registry study

J Rheumatol.

Skougaard M, Jørgensen TS, Rifbjerg-Madsen S, Coates LC, Egeberg A, Amris K, Dreyer L, Højgaard P, Guldberg-Møller J, Merola JF, Frederiksen P, Gudbergsen H, Kristensen LE

doi: 10.3899/jrheum.181412.

Rheumatoid Arthritis

Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

Rheumatology (Oxford).

Vadillo C, Nieto MA, Romero-Bueno F, Leon L, Sanchez-Pernaute O, Rodriguez-Nieto MJ, Freites D, Jover JA, Álvarez-Sala JL, Abasolo L

doi: 10.1093/rheumatology/kez673.

Systemic Sclerosis

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study

Rheumatology (Oxford)

Li Q, Wallace L, Patnaik P, Alves M, Gahlemann M, Kohlbrenner V, Raabe C, Wang JR, Garry EM

doi: 10.1093/rheumatology/keaa547

Related content

Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry

Interstitial lung disease in patients with Common Variable Immunodeficiency Disorders: several different pathologies?

Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry

Mapping risk factors for Cumulative Life Course Impairment (CLCI) in patients with chronic skin diseases - a systematic review

Histological and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

In Psoriatic Arthritis fatigue is driven by inflammation, disease duration, and chronic pain: An observational DANBIO registry study

Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study